MedTrace Logo

Regulated Cannabis Access in Basel

NCT05522205 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 374

Last updated 2024-10-02

No results posted yet for this study

Summary

The randomised controlled study on regulated cannabis access in pharmacies in Basel aims to investigate the effects of regulated cannabis access on consumption behaviour and mental and physical health in comparison to the illegal market.

Conditions

  • Cannabis Use Disorder
  • Mental Health Disorder
  • Physical Illness

Interventions

OTHER

Regulated cannabis access in pharmacies

The study does not investigate the health effects of cannabis. The study investigates the effects of regulated cannabis access on cannabis consumption and health in comparison to the unregulated illegal market.

Sponsors & Collaborators

  • University of Basel

    collaborator OTHER

  • University Psychiatric Clinics Basel

    collaborator NETWORK

  • Psychiatric Services Aargau AG

    collaborator OTHER

  • Health Department of the Canton of Basel-Stadt

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05522205 on ClinicalTrials.gov